Literature DB >> 9090710

Characterization of pulmonary alveolar esterases of the primate Cercopithecus pygerythrus.

H M Leng1, J A Syce.   

Abstract

PURPOSE: To evaluate and classify the hydrolases of the primate lung.
METHODS: Homologous series of aromatic, aliphatic, and choline ester substrates were assayed with the pH-stat method to obtain the Michaelis-Menten kinetic constants, Vmax and K(m), for the enzymes in pulmonary alveolar tissue with esterase activity. Polyacrylamide gel electrophoresis was employed to determine the number of such hydrolytic enzymes. Inhibition studies with selective esterase inhibitors were carried out to classify enzymes as either arylesterases, carboxylesterases, or cholinesterases.
RESULTS: Aromatic, aliphatic, and choline ester drugs were hydrolyzed by alveolar tissue of the primate lung. The catalytic enzymes were more specific for aromatic esters since these were metabolized at faster rates than the other substrates. Aromatic ester hydrolysis was also inhibited by triorthocresylphosphate (TOCP), a potent inhibitor of carboxylesterases. Inhibitors of arylesterases and cholinesterases had minimal effect on the enzymic hydrolysis of all substrates. Polyacrylamide gel electrophoresis demonstrated three enzymes to have esterolytic activity, two (MWs 269 and 281 kDa) of which were sensitive to TOCP and are therefore carboxylesterases. The third enzyme (MW 34 kDa), was unaffected by esterase inhibitors and, thus, cannot be classified as an esterase.
CONCLUSIONS: Primate pulmonary alveolar tissue contains two isozymes of carboxylesterases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9090710     DOI: 10.1023/a:1012004911942

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

3.  Purification and characterization of carboxylesterases from rat lung.

Authors:  R Gaustad; K Sletten; D Løvhaug; F Fonnum
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

Review 4.  Bambuterol- a prodrug-prodrug with built-in hydrolysis brake.

Authors:  L A Svensson
Journal:  Acta Pharm Suec       Date:  1987

5.  Electrophoretic separation of esterases of pulmonary alveolar cells.

Authors:  R Schiff; M A Brunstetter; R L Hunter; C E Cross
Journal:  J Histochem Cytochem       Date:  1970-03       Impact factor: 2.479

6.  Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases.

Authors:  T Minagawa; Y Kohno; T Suwa; A Tsuji
Journal:  Biochem Pharmacol       Date:  1995-05-17       Impact factor: 5.858

7.  Non-specific esterase in the alveolar tissues of hamster lung: an electron microscope study.

Authors:  C Meban
Journal:  Acta Anat (Basel)       Date:  1980

8.  Hydrolysis of carbonates, thiocarbonates, carbamates, and carboxylic esters of alpha-naphthol, beta-naphthol, and p-nitrophenol by human, rat, and mouse liver carboxylesterases.

Authors:  T L Huang; A Székács; T Uematsu; E Kuwano; A Parkinson; B D Hammock
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

9.  Esterase activity of rat muscle.

Authors:  F Crespi; E Pagliacci; G M Rocchini; R Bianchi; M Salmona; S Garattini; E Mussini
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

10.  Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood.

Authors:  N W McCracken; P G Blain; F M Williams
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

View more
  1 in total

1.  Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.

Authors:  J Van Gelder; P Annaert; L Naesens; E De Clercq; G Van den Mooter; R Kinget; P Augustijns
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.